Words matter. Those two words were woven through a Sunday morning address by Alvin C. Powers, MD, ADA President, Medicine & Science. Today’s researchers and clinicians work in a 140-char... Read more

How will diabetes be treated in 2021, 100 years after the discovery of insulin? With selective insulin sensitizers, and by preventing beta-cell dedifferentiation in type 2 diabetes and produ... Read more

Everything you thought you knew about the causes of diabetes is wrong, according to Michael W. Schwartz, MD. Beta-cell dysfunction and insulin resistance are symptoms, not causes. The real p... Read more

During Sunday morning’s Joint ADA/JDRF Symposium—Progress towards an Artificial Pancreas, closed-loop insulin delivery systems received mostly glowing reviews from the session’s expert prese... Read more

Tuesday’s ADA Presidents 
Oral Session will highlight this year’s top eight abstracts as selected by the Scientific Sessions Meeting Planning Committee. The two-hour session, which will brin... Read more

Cardiovascular Safety of Insulin Degludec vs. Insulin Glargine in Patients with Type 2 Diabetes at High Risk of Cardiovascular Events (DEVOTE) Trial Results 2:15 p.m.–3:15 p.m. Monday Halls... Read more

During a Tuesday morning
 symposium, four researchers will explore the effects of cognitive decline and aging as it relates to diabetes care. They will discuss the psychosomatic effects of o... Read more

During Monday afternoon’s 
symposium Successes with Type 1 Diabetes Complications and Survival, four researchers will review the latest data on the development and progression of type 1 diab... Read more

With more than 20,000 children diagnosed with diabetes every year, the American Diabetes Association strives to provide immersive learning experiences through camp programs each year in 25 s... Read more